“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision

The latest episode of the In Vivo podcast features an interview Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies from cord blood, on how they are working across regulatory markets to provide a novel treatment for degenerative diseases.

Episode metadata supplied by the publisher feed · Published Jul 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision

0:00 34:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 34 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on July 16, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!